| Bioactivity | ACAT-IN-2 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example 187. ACAT-IN-2 inhibits NF-κB mediated transcription[1]. |
| Name | ACAT-IN-2 |
| CAS | 199984-55-9 |
| Formula | C29H44N2O4S |
| Molar Mass | 516.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1. |
ACAT-IN-2
CAS: 199984-55-9 F: C29H44N2O4S W: 516.74
ACAT-IN-2 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.